• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

89bio, Inc. - Common Stock (NQ:ETNB)

14.84 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about 89bio, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
October 16, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders
October 08, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
October 08, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
October 06, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
September 27, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, BERY, COMP, ETNB on Behalf of Shareholders
September 23, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of Shareholders
September 20, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
September 19, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders
September 18, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders
September 18, 2025
From Ademi & Fruchter LLP
Via Business Wire
News headline image
89bio, Inc. Announces Agreement to be Acquired by Roche
September 18, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio to Participate in Upcoming Investor Conferences
August 28, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
August 07, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 09, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
June 04, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 09, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio to Participate in Upcoming Investor Conferences
May 06, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
May 01, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio to Participate in the Leerink Partners Global Healthcare Conference
March 03, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
February 27, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 03, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 28, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
January 27, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Provides Business Update and Outlook for 2025
January 13, 2025
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 19, 2024
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024
From 89bio, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap